Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
Itolizumab achieved key secondary endpoint of endoscopic remission of 16.7% compared to 16.7% for adalimumab and 6.7% for placebo
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Subscribe To Our Newsletter & Stay Updated
